Determination of intracellular darunavir by liquid chromatography coupled with fluorescence detection

Daisuke Nagano, Takuya Araki, Tomonori Nakamura, Koujirou Yamamoto

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The concentration of darunavir (DRV) in peripheral blood mono-nuclear cells (PBMCs) was reported to affect the clinical symptoms of patients and the development of drug-resistant viruses. We developed a simple and highly sensitive method to quantify the concentration of DRV in human PBMCs using high-performance liquid chromatography with fluorescence detection. PBMC samples were collected using commercially available tubes for density-gradient centrifugation. To disrupt the cells, we used a heating fragmentation method. To compensate for the disadvantages of the heating fragmentation method, liquid-liquid partitioning was used to destroy the unbroken cells by the degeneration of proteins using an organic solvent. As an analytical column, we used an ODS column. The mobile phase consisted of 20 mmol/L potassium phosphate buffer (pH 4.3)/acetonitrile (57/43, v/v) and was pumped at 1.0 mL/min. The lower limit of quantification was 5 ng/10<sup>6</sup> cells. Good linearity was obtained with 5-100 ng/10<sup>6</sup> cells. The intra- and inter-assay precision and accuracy were <15%. Because our method makes possible the measurement of DRV concentration in PBMCs at medical facilities or laboratories without tandem mass spectrometry systems, we believe that it will contribute to clinical studies and will improve the medical treatment of human immunodeficiency virus infections with DRV.

Original languageEnglish
Pages (from-to)1021-1025
Number of pages5
JournalJournal of Chromatographic Science
Volume52
Issue number9
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Liquid chromatography
Blood
Fluorescence
Viruses
Assays
Heating
Centrifugation
High performance liquid chromatography
Liquids
Organic solvents
Mass spectrometry
Buffers
Darunavir
Pharmaceutical Preparations
Proteins

ASJC Scopus subject areas

  • Analytical Chemistry

Cite this

Determination of intracellular darunavir by liquid chromatography coupled with fluorescence detection. / Nagano, Daisuke; Araki, Takuya; Nakamura, Tomonori; Yamamoto, Koujirou.

In: Journal of Chromatographic Science, Vol. 52, No. 9, 2014, p. 1021-1025.

Research output: Contribution to journalArticle

@article{e6120d2fb5e7428480bafd884f513287,
title = "Determination of intracellular darunavir by liquid chromatography coupled with fluorescence detection",
abstract = "The concentration of darunavir (DRV) in peripheral blood mono-nuclear cells (PBMCs) was reported to affect the clinical symptoms of patients and the development of drug-resistant viruses. We developed a simple and highly sensitive method to quantify the concentration of DRV in human PBMCs using high-performance liquid chromatography with fluorescence detection. PBMC samples were collected using commercially available tubes for density-gradient centrifugation. To disrupt the cells, we used a heating fragmentation method. To compensate for the disadvantages of the heating fragmentation method, liquid-liquid partitioning was used to destroy the unbroken cells by the degeneration of proteins using an organic solvent. As an analytical column, we used an ODS column. The mobile phase consisted of 20 mmol/L potassium phosphate buffer (pH 4.3)/acetonitrile (57/43, v/v) and was pumped at 1.0 mL/min. The lower limit of quantification was 5 ng/106 cells. Good linearity was obtained with 5-100 ng/106 cells. The intra- and inter-assay precision and accuracy were <15{\%}. Because our method makes possible the measurement of DRV concentration in PBMCs at medical facilities or laboratories without tandem mass spectrometry systems, we believe that it will contribute to clinical studies and will improve the medical treatment of human immunodeficiency virus infections with DRV.",
author = "Daisuke Nagano and Takuya Araki and Tomonori Nakamura and Koujirou Yamamoto",
year = "2014",
doi = "10.1093/chromsci/bmt147",
language = "English",
volume = "52",
pages = "1021--1025",
journal = "Journal of Chromatographic Science",
issn = "0021-9665",
publisher = "Preston Publications",
number = "9",

}

TY - JOUR

T1 - Determination of intracellular darunavir by liquid chromatography coupled with fluorescence detection

AU - Nagano, Daisuke

AU - Araki, Takuya

AU - Nakamura, Tomonori

AU - Yamamoto, Koujirou

PY - 2014

Y1 - 2014

N2 - The concentration of darunavir (DRV) in peripheral blood mono-nuclear cells (PBMCs) was reported to affect the clinical symptoms of patients and the development of drug-resistant viruses. We developed a simple and highly sensitive method to quantify the concentration of DRV in human PBMCs using high-performance liquid chromatography with fluorescence detection. PBMC samples were collected using commercially available tubes for density-gradient centrifugation. To disrupt the cells, we used a heating fragmentation method. To compensate for the disadvantages of the heating fragmentation method, liquid-liquid partitioning was used to destroy the unbroken cells by the degeneration of proteins using an organic solvent. As an analytical column, we used an ODS column. The mobile phase consisted of 20 mmol/L potassium phosphate buffer (pH 4.3)/acetonitrile (57/43, v/v) and was pumped at 1.0 mL/min. The lower limit of quantification was 5 ng/106 cells. Good linearity was obtained with 5-100 ng/106 cells. The intra- and inter-assay precision and accuracy were <15%. Because our method makes possible the measurement of DRV concentration in PBMCs at medical facilities or laboratories without tandem mass spectrometry systems, we believe that it will contribute to clinical studies and will improve the medical treatment of human immunodeficiency virus infections with DRV.

AB - The concentration of darunavir (DRV) in peripheral blood mono-nuclear cells (PBMCs) was reported to affect the clinical symptoms of patients and the development of drug-resistant viruses. We developed a simple and highly sensitive method to quantify the concentration of DRV in human PBMCs using high-performance liquid chromatography with fluorescence detection. PBMC samples were collected using commercially available tubes for density-gradient centrifugation. To disrupt the cells, we used a heating fragmentation method. To compensate for the disadvantages of the heating fragmentation method, liquid-liquid partitioning was used to destroy the unbroken cells by the degeneration of proteins using an organic solvent. As an analytical column, we used an ODS column. The mobile phase consisted of 20 mmol/L potassium phosphate buffer (pH 4.3)/acetonitrile (57/43, v/v) and was pumped at 1.0 mL/min. The lower limit of quantification was 5 ng/106 cells. Good linearity was obtained with 5-100 ng/106 cells. The intra- and inter-assay precision and accuracy were <15%. Because our method makes possible the measurement of DRV concentration in PBMCs at medical facilities or laboratories without tandem mass spectrometry systems, we believe that it will contribute to clinical studies and will improve the medical treatment of human immunodeficiency virus infections with DRV.

UR - http://www.scopus.com/inward/record.url?scp=84931042174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931042174&partnerID=8YFLogxK

U2 - 10.1093/chromsci/bmt147

DO - 10.1093/chromsci/bmt147

M3 - Article

VL - 52

SP - 1021

EP - 1025

JO - Journal of Chromatographic Science

JF - Journal of Chromatographic Science

SN - 0021-9665

IS - 9

ER -